A DNA fragment with an alpha-phosphorothioate nucleotide at one end is asymmetrically blocked from digestion by exonuclease III and can be replicated in vivo - PubMed (original) (raw)

A DNA fragment with an alpha-phosphorothioate nucleotide at one end is asymmetrically blocked from digestion by exonuclease III and can be replicated in vivo

S D Putney et al. Proc Natl Acad Sci U S A. 1981 Dec.

Abstract

2'-Deoxyadenosine 5'-O-(1-thiotriphosphate) (dATP[alpha S]) was introduced into the 3' ends of DNA restriction fragments with Escherichia coli DNA polymerase I to give phosphorothioate internucleotide linkages. Such "capped" 3' ends were found to be resistant to exonuclease III digestion. Moreover, the resistance to digestion is great enough that, under conditions used by us, just one strand of a double helix is digested by exonuclease III when a cap is placed at only one end; when digestion is carried to completion, this results in production of intact single strands. When digestion with exonuclease III is limited and is followed by S1 nuclease treatment, double-stranded DNA fragments asymmetrically shortened from just one side are produced. In this was thousands of nucleotides can be selectively removed from one end of a restriction fragment. In vitro introduction of phosphorothioate linkages into one end of a linearized replicative plasmid, followed by exonuclease III and S1 nuclease treatments, gives rise to truncated forms that, upon circularization by blunt-end ligation, transform E. coli and replicate in vivo.

PubMed Disclaimer

Cited by

Harnessing sulfur-binding domains to separate Sp and Rp isomers of phosphorothioate oligonucleotides.
Ge F, Wang Y, Liu J, Yu H, Liu G, Deng Z, He X. Ge F, et al. Appl Microbiol Biotechnol. 2024 Aug 27;108(1):448. doi: 10.1007/s00253-024-13283-3. Appl Microbiol Biotechnol. 2024. PMID: 39190037 Free PMC article.
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy.
Liu WW, Zheng SQ, Li T, Fei YF, Wang C, Zhang S, Wang F, Jiang GM, Wang H. Liu WW, et al. Signal Transduct Target Ther. 2024 Mar 27;9(1):70. doi: 10.1038/s41392-024-01777-5. Signal Transduct Target Ther. 2024. PMID: 38531882 Free PMC article. Review.
An autocatalytic CRISPR-Cas amplification effect propelled by the LNA-modified split activators for DNA sensing.
Sun K, Pu L, Chen C, Chen M, Li K, Li X, Li H, Geng J. Sun K, et al. Nucleic Acids Res. 2024 Apr 24;52(7):e39. doi: 10.1093/nar/gkae176. Nucleic Acids Res. 2024. PMID: 38477342 Free PMC article.
An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complex.
Shannon A, Chazot A, Feracci M, Falcou C, Fattorini V, Selisko B, Good S, Moussa A, Sommadossi JP, Ferron F, Alvarez K, Canard B. Shannon A, et al. Nucleic Acids Res. 2024 Feb 9;52(3):1325-1340. doi: 10.1093/nar/gkad1194. Nucleic Acids Res. 2024. PMID: 38096103 Free PMC article.
Clinical Pharmacokinetics of Approved RNA Therapeutics.
Jo SJ, Chae SU, Lee CB, Bae SK. Jo SJ, et al. Int J Mol Sci. 2023 Jan 1;24(1):746. doi: 10.3390/ijms24010746. Int J Mol Sci. 2023. PMID: 36614189 Free PMC article. Review.

References

1. Biochemistry. 1969 Dec;8(12):4897-904 - PubMed
1. Biochemistry. 1975 Aug 26;14(17):3787-94 - PubMed
1. Nucleic Acids Res. 1975 Sep;2(9):1459-92 - PubMed
1. Biochemistry. 1976 Feb 24;15(4):734-40 - PubMed
1. Proc Natl Acad Sci U S A. 1976 Sep;73(9):2987-90 - PubMed

A DNA fragment with an alpha-phosphorothioate nucleotide at one end is asymmetrically blocked from digestion by exonuclease III and can be replicated in vivo - PubMed (original) (raw)